These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 877419)

  • 1. Urinary excretion of phenolic metabolites of N-(n-propyl)amphetamine in man.
    Coutts RT; Dawson GW
    Res Commun Chem Pathol Pharmacol; 1977 Jun; 17(2):349-52. PubMed ID: 877419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo phenolic metabolites of N-alkylamphetamines in the rat. Evidence in favor of catechol formation.
    Coutts RT; Dawson GW; Kazakoff CW; Wong JY
    Drug Metab Dispos; 1976; 4(3):256-61. PubMed ID: 6230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interindividual and interspecies variation in the metabolism of the hallucinogen 4-methoxyamphetamine.
    Kitchen I; Tremblay J; André J; Dring LG; Idle JR; Smith RL; Williams RT
    Xenobiotica; 1979 Jul; 9(7):397-404. PubMed ID: 582863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo and in vitro o-methylation of 1-(3,4-dihydroxyphenyl)-2-(n-propyl-amino) propane - an intermediate in N-(N-propyl) amphetamine metabolism.
    Coutts RT; Jones GR
    Res Commun Chem Pathol Pharmacol; 1982 Apr; 36(1):173-6. PubMed ID: 7079586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the metabolism of the amphetamine-derived antispasmodic drug mebeverine: gas chromatography-mass spectrometry studies on rat liver microsomes and on human urine.
    Kraemer T; Bickeboeller-Friedrich J; Maurer HH
    Drug Metab Dispos; 2000 Mar; 28(3):339-47. PubMed ID: 10681380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolism of 1-phenyl-2-(N-methyl-N-benzylamino)propane (benzphetamine) and 1-phenyl-2-(N-methyl-N-furfurylamino)propane (furfenorex) in man.
    Inoue T; Suzuki S
    Xenobiotica; 1986 Jul; 16(7):691-8. PubMed ID: 3751123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro metabolism of 1-phenyl-2-(n-propylamino) propane (N-propylamphetamine) by rat liver homogenates.
    Coutts RT; Dawson GW; Beckett AH
    J Pharm Pharmacol; 1976 Nov; 28(11):815-21. PubMed ID: 11289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and measurement of urinary metabolites of afloqualone in man.
    Furuuchi S; Otsuka M; Miura Y; Harigaya S
    Drug Metab Dispos; 1983; 11(4):371-6. PubMed ID: 6137346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biotransformation of aliphatic formamides: metabolites of (+-)-N-methyl-N-(1-methyl-3,3-diphenylpropyl) formamide in rats.
    Slatter JG; Mutlib AE; Abbott FS
    Biomed Environ Mass Spectrom; 1989 Sep; 18(9):690-701. PubMed ID: 2790257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary output changes in racemic ethylamphetamine and optical activity discrimination in rat urine by HPLC analysis.
    Matsushima K; Nagai T; Kanaya H; Kato Y; Takahashi M; Kamiyama S
    Nihon Hoigaku Zasshi; 1998 Feb; 52(1):19-26. PubMed ID: 9591399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic production of amphetamine following administration of clobenzorex.
    Valtier S; Cody JT
    J Forensic Sci; 1999 Jan; 44(1):17-22. PubMed ID: 9987865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo formation of dopamine from 3,4-methylenedioxyphenethylamine in the rat.
    Schweitzer JW; Schwartz R; Friedhoff AJ
    Arch Int Pharmacodyn Ther; 1978 Jan; 231(1):21-9. PubMed ID: 637621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of diuretics on the excretion and metabolism of doping agents. III. Etilamfetamine.
    Delbeke FT; Debackere M
    Arzneimittelforschung; 1986 Sep; 36(9):1413-6. PubMed ID: 3790195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meperidine metabolites: identification of N-hydroxynormeperidine and a hydroxy-methoxy derivative of meperidine in biological fluids.
    Stillwell WG; Myran CS; Stewart JT
    Res Commun Chem Pathol Pharmacol; 1976 Aug; 14(4):605-19. PubMed ID: 986679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism and excretion of ropivacaine in humans.
    Halldin MM; Bredberg E; Angelin B; Arvidsson T; Askemark Y; Elofsson S; Widman M
    Drug Metab Dispos; 1996 Sep; 24(9):962-8. PubMed ID: 8886605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotransformation of urapidil: isolation and identification of metabolites in mouse, rat, dog and man.
    Sturm E; Zech K
    Biomed Mass Spectrom; 1984 May; 11(5):211-6. PubMed ID: 6743765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural characterization of urinary metabolites of the antiarrhythmic drug encainide in human subjects.
    Jajoo HK; Mayol RF; LaBudde JA; Blair IA
    Drug Metab Dispos; 1990; 18(1):28-35. PubMed ID: 1970774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary metabolite profile of phenyl and o-cresyl glycidyl ether in rats: identification of a novel pathway leading to N-acetylserine O-conjugates.
    de Rooij BM; Commandeur JN; Hommes JW; Aalbers T; Groot EJ; Vermeulen NP
    Chem Res Toxicol; 1998 Feb; 11(2):111-8. PubMed ID: 9511902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of an anxiolytic imidazobenzodiazepine by the dog.
    Kolis SJ; Postma EJ; Williams TH; Sasso GJ; Schwartz MA
    Drug Metab Dispos; 1983; 11(4):324-8. PubMed ID: 6137338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of urinary metabolites from Sprague-Dawley rats and B6C3F1 mice exposed to [1,2,3,4-13C]butadiene.
    Nauhaus SK; Fennell TR; Asgharian B; Bond JA; Sumner SC
    Chem Res Toxicol; 1996 Jun; 9(4):764-73. PubMed ID: 8831821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.